KHSC is expanding access to disease-modifying drugs and developing a blood test to help identify patients who may benefit from earlier care.
Kingston Health Sciences Centre (KHSC) is among the first health sciences centres in Canada to offer access to new Alzheimer’s treatments, bringing specialized care closer to home for patients across southeastern Ontario.
The disease-modifying drugs are designed to slow Alzheimer’s progression in eligible patients, with the greatest benefits expected when treatment begins in the early stages.
Memory disorders specialist Dr. Durjoy Lahiri is working to establish Kingston as a regional referral centre for patients who would otherwise travel to Toronto or Ottawa.
Lahiri estimates 25 to 30 patients could receive infusions through KHSC within the next six to nine months.
KHSC has also developed a blood test to help identify patients who may benefit from further assessment. The work received funding from the University Hospitals Kingston Foundation and YGK Healthcare Champions.
The treatments are not a cure, but they aim to help eligible patients maintain their independence for longer.
Story by Alyssa Brush
United Way KFL&A coat drive returns with 10 drop-off locations across the region
Seeley’s Bay retiree wins $50,000 on scratch ticket
Frontenacs' Landon Wright launches initiative to support cancer patients
OPP dismantle illegal cannabis sites in Stone Mills and Madoc
2026 Kingston Municipal Elections: District 12 - Pittsburgh
